TINA VOISIN: Open Payments
NPI 1437483278 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,809 in 77 payments from 24 companies in 2025. Trend: 2023 $2,799 · 2024 $2,290 · 2025 $1,809
Food & beverage: $1,709Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $357 |
| Insmed, Inc. | 6 | $183 |
| Theratechnologies Inc. | 6 | $177 |
| Paratek Pharmaceuticals, Inc. | 10 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $141 |
| Merck Sharp & Dohme LLC | 4 | $110 |
| Astellas Pharma US Inc | 1 | $100 |
| SHIELD THERAPEUTICS INC | 1 | $88 |
| Aimmune Therapeutics, Inc. | 3 | $68 |
| Lilly USA, LLC | 3 | $64 |
Products named: Arikayce, EGRIFTA, NUZYRA, Kerendia, EMBLAVEO, VRAYLAR, ZERBAXA, ACCRUFER.
Industry payments across FL — which companies pay providers there.
